New cancer drug trial seeks to control advanced tumors
NCT ID NCT06736704
Summary
This study is testing a new medicine, SNV4818, for people with advanced solid tumors that have a specific genetic change (PIK3CA mutation). The main goals are to find the safest and most effective dose of SNV4818, both by itself and when combined with other cancer drugs. Researchers will also check if the medicine helps control the cancer and how the body processes it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chris O'Brien Lifehouse
RECRUITINGCamperdown, New South Wales, 2050, Australia
-
Linear Clinical Research
RECRUITINGNedlands, Western Australia, 6009, Australia
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
-
Monash Health
RECRUITINGClayton, Victoria, 3168, Australia
-
Peter MacCallum Cancer Centre
RECRUITINGMelbourne, Victoria, 3000, Australia
-
Sarah Cannon Research Institute
RECRUITINGNashville, Tennessee, 37203, United States
-
Scientia Clinical Research
RECRUITINGRandwick, New South Wales, 2031, Australia
-
The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate
RECRUITINGLos Angeles, California, 90025, United States
-
The Ottawa Hospital Cancer Centre
RECRUITINGOttawa, Ontario, K1H 8L6, Canada
-
The University of Texas M.D. Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
Thomas Jefferson University-Sidney Kimmel Cancer Center
RECRUITINGPhiladelphia, Pennsylvania, 19107, United States
-
University Health Network, Princess Margaret Cancer Centre
RECRUITINGToronto, Ontario, M5G 2M9, Canada
Conditions
Explore the condition pages connected to this study.